Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
Phase 2
Completed
- Conditions
- Ocular Hypertension
- Registration Number
- NCT00300443
- Lead Sponsor
- Allergan
- Brief Summary
The purpose of this study is to assess the safety and efficacy of bimatoprost in patients with glaucoma or ocular hypertension
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 561
Inclusion Criteria
- Clinical diagnosis of glaucoma or ocular hypertension in both eyes
- Patient requires IOP-lowering drug in both eyes
Exclusion Criteria
- Uncontrolled medical conditions
- Ocular seasonal allergies within the past 2 years
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Lowering intraocular pressure (IOP)
- Secondary Outcome Measures
Name Time Method